Cancer trials often involve complex treatments and vulnerable patient populations, making safety monitoring essential. DSMBs help to:
Protect patient well-being by closely monitoring adverse events. Ensure the scientific integrity of the trial. Make recommendations on whether to continue, modify, or terminate a trial based on interim data.
